Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 157 Pages
Report ld: 6468296
Request Sample
Customized Report
Sterile Serological Pipette Market Size(US$)

CAGR 2026-2032
5.2%
Market Size,2032
USD 380
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sterile Serological Pipette competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report delivers a comprehensive overview of the global Sterile Serological Pipette market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sterile Serological Pipette. The Sterile Serological Pipette market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sterile Serological Pipette market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sterile Serological Pipette manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sterile Serological Pipette manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sterile Serological Pipette sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Sterile Serological Pipette Market Overview
1.1 Product Definition
1.2 Sterile Serological Pipette by Type
1.2.1 Global Sterile Serological Pipette Market Value by Type: 2025 vs 2032
1.2.2 2 ml
1.2.3 5 ml
1.2.4 10 ml
1.2.5 25 ml
1.2.6 Others
1.3 Sterile Serological Pipette by Application
1.3.1 Global Sterile Serological Pipette Market Value by Application: 2025 vs 2032
1.3.2 Cell Culture
1.3.3 Bacteriology
1.3.4 Clinical Research
1.3.5 Others
1.4 Global Sterile Serological Pipette Market Size Estimates and Forecasts
1.4.1 Global Sterile Serological Pipette Revenue 2021–2032
1.4.2 Global Sterile Serological Pipette Sales 2021–2032
1.4.3 Global Sterile Serological Pipette Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Sterile Serological Pipette Market Competition by Manufacturers
2.1 Global Sterile Serological Pipette Sales Market Share by Manufacturers (2021–2026)
2.2 Global Sterile Serological Pipette Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Sterile Serological Pipette Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Sterile Serological Pipette, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Sterile Serological Pipette, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Sterile Serological Pipette, Product Types and Applications
2.7 Global Key Manufacturers of Sterile Serological Pipette, Date of Entry into the Industry
2.8 Global Sterile Serological Pipette Market Competitive Situation and Trends
2.8.1 Global Sterile Serological Pipette Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Sterile Serological Pipette Players Market Share by Revenue
2.8.3 Global Sterile Serological Pipette Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sterile Serological Pipette Market Scenario by Region
3.1 Global Sterile Serological Pipette Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Sterile Serological Pipette Sales by Region: 2021–2032
3.2.1 Global Sterile Serological Pipette Sales by Region: 2021–2026
3.2.2 Global Sterile Serological Pipette Sales by Region: 2027–2032
3.3 Global Sterile Serological Pipette Revenue by Region: 2021–2032
3.3.1 Global Sterile Serological Pipette Revenue by Region: 2021–2026
3.3.2 Global Sterile Serological Pipette Revenue by Region: 2027–2032
3.4 North America Sterile Serological Pipette Market Facts & Figures by Country
3.4.1 North America Sterile Serological Pipette Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Sterile Serological Pipette Sales by Country (2021–2032)
3.4.3 North America Sterile Serological Pipette Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sterile Serological Pipette Market Facts & Figures by Country
3.5.1 Europe Sterile Serological Pipette Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Sterile Serological Pipette Sales by Country (2021–2032)
3.5.3 Europe Sterile Serological Pipette Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sterile Serological Pipette Market Facts & Figures by Region
3.6.1 Asia Pacific Sterile Serological Pipette Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Sterile Serological Pipette Sales by Region (2021–2032)
3.6.3 Asia Pacific Sterile Serological Pipette Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sterile Serological Pipette Market Facts & Figures by Country
3.7.1 Latin America Sterile Serological Pipette Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Sterile Serological Pipette Sales by Country (2021–2032)
3.7.3 Latin America Sterile Serological Pipette Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sterile Serological Pipette Market Facts & Figures by Country
3.8.1 Middle East and Africa Sterile Serological Pipette Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Sterile Serological Pipette Sales by Country (2021–2032)
3.8.3 Middle East and Africa Sterile Serological Pipette Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sterile Serological Pipette Sales by Type (2021–2032)
4.1.1 Global Sterile Serological Pipette Sales by Type (2021–2026)
4.1.2 Global Sterile Serological Pipette Sales by Type (2027–2032)
4.1.3 Global Sterile Serological Pipette Sales Market Share by Type (2021–2032)
4.2 Global Sterile Serological Pipette Revenue by Type (2021–2032)
4.2.1 Global Sterile Serological Pipette Revenue by Type (2021–2026)
4.2.2 Global Sterile Serological Pipette Revenue by Type (2027–2032)
4.2.3 Global Sterile Serological Pipette Revenue Market Share by Type (2021–2032)
4.3 Global Sterile Serological Pipette Price by Type (2021–2032)
5 Segment by Application
5.1 Global Sterile Serological Pipette Sales by Application (2021–2032)
5.1.1 Global Sterile Serological Pipette Sales by Application (2021–2026)
5.1.2 Global Sterile Serological Pipette Sales by Application (2027–2032)
5.1.3 Global Sterile Serological Pipette Sales Market Share by Application (2021–2032)
5.2 Global Sterile Serological Pipette Revenue by Application (2021–2032)
5.2.1 Global Sterile Serological Pipette Revenue by Application (2021–2026)
5.2.2 Global Sterile Serological Pipette Revenue by Application (2027–2032)
5.2.3 Global Sterile Serological Pipette Revenue Market Share by Application (2021–2032)
5.3 Global Sterile Serological Pipette Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Scilogex
6.1.1 Scilogex Company Information
6.1.2 Scilogex Description and Business Overview
6.1.3 Scilogex Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Scilogex Sterile Serological Pipette Product Portfolio
6.1.5 Scilogex Recent Developments/Updates
6.2 Eppendorf
6.2.1 Eppendorf Company Information
6.2.2 Eppendorf Description and Business Overview
6.2.3 Eppendorf Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eppendorf Sterile Serological Pipette Product Portfolio
6.2.5 Eppendorf Recent Developments/Updates
6.3 Starlab
6.3.1 Starlab Company Information
6.3.2 Starlab Description and Business Overview
6.3.3 Starlab Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Starlab Sterile Serological Pipette Product Portfolio
6.3.5 Starlab Recent Developments/Updates
6.4 VWR International
6.4.1 VWR International Company Information
6.4.2 VWR International Description and Business Overview
6.4.3 VWR International Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 VWR International Sterile Serological Pipette Product Portfolio
6.4.5 VWR International Recent Developments/Updates
6.5 CELLTREAT Scientific Products
6.5.1 CELLTREAT Scientific Products Company Information
6.5.2 CELLTREAT Scientific Products Description and Business Overview
6.5.3 CELLTREAT Scientific Products Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CELLTREAT Scientific Products Sterile Serological Pipette Product Portfolio
6.5.5 CELLTREAT Scientific Products Recent Developments/Updates
6.6 USA Scientific
6.6.1 USA Scientific Company Information
6.6.2 USA Scientific Description and Business Overview
6.6.3 USA Scientific Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 USA Scientific Sterile Serological Pipette Product Portfolio
6.6.5 USA Scientific Recent Developments/Updates
6.7 CAPP
6.7.1 CAPP Company Information
6.7.2 CAPP Description and Business Overview
6.7.3 CAPP Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CAPP Sterile Serological Pipette Product Portfolio
6.7.5 CAPP Recent Developments/Updates
6.8 Globe Scientific
6.8.1 Globe Scientific Company Information
6.8.2 Globe Scientific Description and Business Overview
6.8.3 Globe Scientific Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Globe Scientific Sterile Serological Pipette Product Portfolio
6.8.5 Globe Scientific Recent Developments/Updates
6.9 Abdos Labtech
6.9.1 Abdos Labtech Company Information
6.9.2 Abdos Labtech Description and Business Overview
6.9.3 Abdos Labtech Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Abdos Labtech Sterile Serological Pipette Product Portfolio
6.9.5 Abdos Labtech Recent Developments/Updates
6.10 SPL Life Sciences
6.10.1 SPL Life Sciences Company Information
6.10.2 SPL Life Sciences Description and Business Overview
6.10.3 SPL Life Sciences Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 SPL Life Sciences Sterile Serological Pipette Product Portfolio
6.10.5 SPL Life Sciences Recent Developments/Updates
6.11 MIDSCI
6.11.1 MIDSCI Company Information
6.11.2 MIDSCI Description and Business Overview
6.11.3 MIDSCI Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 MIDSCI Sterile Serological Pipette Product Portfolio
6.11.5 MIDSCI Recent Developments/Updates
6.12 Thermo Fisher Scientific
6.12.1 Thermo Fisher Scientific Company Information
6.12.2 Thermo Fisher Scientific Description and Business Overview
6.12.3 Thermo Fisher Scientific Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Thermo Fisher Scientific Sterile Serological Pipette Product Portfolio
6.12.5 Thermo Fisher Scientific Recent Developments/Updates
6.13 Tarsons
6.13.1 Tarsons Company Information
6.13.2 Tarsons Description and Business Overview
6.13.3 Tarsons Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Tarsons Sterile Serological Pipette Product Portfolio
6.13.5 Tarsons Recent Developments/Updates
6.14 Medline Industries
6.14.1 Medline Industries Company Information
6.14.2 Medline Industries Description and Business Overview
6.14.3 Medline Industries Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Medline Industries Sterile Serological Pipette Product Portfolio
6.14.5 Medline Industries Recent Developments/Updates
6.15 Corning
6.15.1 Corning Company Information
6.15.2 Corning Description and Business Overview
6.15.3 Corning Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Corning Sterile Serological Pipette Product Portfolio
6.15.5 Corning Recent Developments/Updates
6.16 Greiner Bio-One
6.16.1 Greiner Bio-One Company Information
6.16.2 Greiner Bio-One Description and Business Overview
6.16.3 Greiner Bio-One Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Greiner Bio-One Sterile Serological Pipette Product Portfolio
6.16.5 Greiner Bio-One Recent Developments/Updates
6.17 Gilson
6.17.1 Gilson Company Information
6.17.2 Gilson Description and Business Overview
6.17.3 Gilson Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Gilson Sterile Serological Pipette Product Portfolio
6.17.5 Gilson Recent Developments/Updates
6.18 Sartorius
6.18.1 Sartorius Company Information
6.18.2 Sartorius Description and Business Overview
6.18.3 Sartorius Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Sartorius Sterile Serological Pipette Product Portfolio
6.18.5 Sartorius Recent Developments/Updates
6.19 Bio-Rad Laboratories
6.19.1 Bio-Rad Laboratories Company Information
6.19.2 Bio-Rad Laboratories Description and Business Overview
6.19.3 Bio-Rad Laboratories Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Bio-Rad Laboratories Sterile Serological Pipette Product Portfolio
6.19.5 Bio-Rad Laboratories Recent Developments/Updates
6.20 Nest Scientific
6.20.1 Nest Scientific Company Information
6.20.2 Nest Scientific Description and Business Overview
6.20.3 Nest Scientific Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Nest Scientific Sterile Serological Pipette Product Portfolio
6.20.5 Nest Scientific Recent Developments/Updates
6.21 Biologix
6.21.1 Biologix Company Information
6.21.2 Biologix Description and Business Overview
6.21.3 Biologix Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Biologix Sterile Serological Pipette Product Portfolio
6.21.5 Biologix Recent Developments/Updates
6.22 TPP
6.22.1 TPP Company Information
6.22.2 TPP Description and Business Overview
6.22.3 TPP Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 TPP Sterile Serological Pipette Product Portfolio
6.22.5 TPP Recent Developments/Updates
6.23 Sarstedt
6.23.1 Sarstedt Company Information
6.23.2 Sarstedt Description and Business Overview
6.23.3 Sarstedt Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Sarstedt Sterile Serological Pipette Product Portfolio
6.23.5 Sarstedt Recent Developments/Updates
6.24 Merck
6.24.1 Merck Company Information
6.24.2 Merck Description and Business Overview
6.24.3 Merck Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Merck Sterile Serological Pipette Product Portfolio
6.24.5 Merck Recent Developments/Updates
6.25 Argos Technologies
6.25.1 Argos Technologies Company Information
6.25.2 Argos Technologies Description and Business Overview
6.25.3 Argos Technologies Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Argos Technologies Sterile Serological Pipette Product Portfolio
6.25.5 Argos Technologies Recent Developments/Updates
6.26 HiMedia
6.26.1 HiMedia Company Information
6.26.2 HiMedia Description and Business Overview
6.26.3 HiMedia Sterile Serological Pipette Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 HiMedia Sterile Serological Pipette Product Portfolio
6.26.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sterile Serological Pipette Industry Chain Analysis
7.2 Sterile Serological Pipette Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sterile Serological Pipette Production Mode & Process Analysis
7.4 Sterile Serological Pipette Sales and Marketing
7.4.1 Sterile Serological Pipette Sales Channels
7.4.2 Sterile Serological Pipette Distributors
7.5 Sterile Serological Pipette Customer Analysis
8 Sterile Serological Pipette Market Dynamics
8.1 Sterile Serological Pipette Industry Trends
8.2 Sterile Serological Pipette Market Drivers
8.3 Sterile Serological Pipette Market Challenges
8.4 Sterile Serological Pipette Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 168
USD 3950.00
(Single User License)
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 128
USD 4250.00
(Single User License)
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 213
USD 4900.00
(Single User License)
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 187
USD 3950.00
(Single User License)
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-13
Pages: 120
USD 2900.00
(Single User License)
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published Date: 2024-04-26
Pages: 126
USD 4900.00
(Single User License)
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 113
USD 2900.00
(Single User License)
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-06-16
Pages: 168
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 128
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 213
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 187
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-13
Pages: 120
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published: 2024-04-26
Pages: 126
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now